Stay updated on Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page's revision label changed from v3.5.0 to v3.5.2. This appears to be a backend/UI update with no impact on the study details presented.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be an administrative update with no changes to study content or user workflow.SummaryDifference0.1%

- Check74 days agoChange DetectedAdministrative site updates were made: the page shows Revision: v3.4.2 and the operating-status notice about government funding lapse was removed, along with the prior Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check81 days agoChange DetectedThe addition includes a site-wide notice about a lapse in government funding and NIH Clinical Center status, plus a version update from 3.4.0 to 3.4.1; these do not affect the study data or details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check88 days agoChange DetectedAdded a glossary display and small text updates, including a capitalization change in the QC label ('Last Update Submitted that Met QC Criteria') and a revision/version update to v3.4.0 (replacing v3.3.4).SummaryDifference0.2%

Stay in the know with updates to Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.